Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death. (Record no. 24747071)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01423 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517023446.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201505s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1432-0584 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s00277-015-2316-0 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Pfirrmann, Markus |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150526 |
245 00 - TITLE STATEMENT | |
Title | Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Annals of hematology |
Date of publication, distribution, etc. | Apr 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | S209-18 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cause of Death |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Practice Guidelines as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proportional Hazards Models |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein-Tyrosine Kinases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Remission Induction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Assessment |
General subdivision | methods |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lauseker, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hoffmann, Verena S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hasford, Joerg |
773 0# - HOST ITEM ENTRY | |
Title | Annals of hematology |
Related parts | vol. 94 Suppl 2 |
-- | p. S209-18 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00277-015-2316-0">https://doi.org/10.1007/s00277-015-2316-0</a> |
Public note | Available from publisher's website |
No items available.